Author:
Sevostyanova T. A.,Aksenova V. A.,Belilovsky E. M.
Abstract
For example, a megacity of 10 years and an analysis of the problems, specific prevention of tuberculosis. Mass vaccination against tuberculosis leads to a reduction in morbidity and mortality from the disease according to Moscow. The main problems of vaccine prevention of tuberculosis in Moscow are to reduce vaccination coverage of newborns due to increased number of failures parents. The frequency of severe complications (BCG osteitis) was 0,004%, frequency of pulmonary complications - 0,005% (lymphadenitis), 0,01% (cold abscesses) to 100 thousand vaccinated. Possible complications of vaccine-B are not an occasion to review the policy on primary vaccination with BCG.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Epidemiology
Reference18 articles.
1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2013. Stockholm, European Centre for Disease Prevention and Control. 2013.
2. Blasi F., Reichman L.B., Migliori G.B. Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe. Eur. Respir. J. 2012; 40: 806 – 808.
3. Veen J., Migliori G.B., Raviglione M., Rieder H.L., Dara M., Falzon D. et al. Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops. Eur. Respir. J. 2011; 37: 950 – 959.
4. Aksenovа V.A. Modern approaches to the use of anti-TB vaccination. Epidemiology and Vaccinal Prevention. 2004; 4: 13 – 16 (in Russian).
5. Sevostyanova T.A., Aksenovа V.A., Levi D.T. Problems of modern vaccine prophylaxis of tuberculosis in Russia. Proceedings of the 1st Congress of the National Association of TB specialists. St. Petersburg. 2012: 197 – 199 (in Russian).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献